CD8A and infection: Using IFNγ ELISpot and flow cytometry, we compared virus-specific CD4+ and CD8+ T-cell responses over 18 months post-infection with ancestral, alpha or delta SARS-CoV-2 variants and demonstrated that CD8+ TSCM is a relevant marker of long-term protection.